North America Animal Model Market to Surpass USD 18 Billion By 2027

September 13, 2021

According to the research report titled ‘North America Animal Model Market Forecast 2027 By Technology, By Animal Type, By Application, By Use, By End-use, Research Report, Regional Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with Market Study Report, North America animal model market is projected to record a CAGR of 8.8% over 2021-2027 and reach a valuation of USD 18.1 billion by the end of the forecast period.

Increasing pharmaceutical research and development activities, escalating demand for personalized medicine, and rising penetration of CRISPR/Cas9 technology are promulgating North America animal model market growth. Further, government investments to improve medical facilities, and broad application scope of animal model in healthcare sector is positively impacting the industry outlook.

Request sample copy of this Report:

For the uninitiated, animal models are prominently utilized as specimens for performing scientific experiments to decipher the effects of a particular disease on the human body, so as develop effective treatments and medications for the conditional. The anatomical and physiological attributes of some animals are nearly identical to that of humans, helping researchers better understand the human response to diseases.

Based on technology, North America animal model market is fragmented into CRISPR, embryonic stem cell injection, microinjection, nuclear transfer, and others, among which, the foremost segment is anticipated to garner strong returns with a CAGR of 8.8% through 2027. The segment growth is attributable to widespread use of technology by researchers for gene editing activities that address defects found in the genetic structure of a species.

In terms of animal type, the industry is categorized into mice, rats, birds, first, cattle, amphibians, pigs, guinea pigs, dogs, cats, monkeys, sheep, rabbits, hamsters, and others. Among these, rats segment is slated to witness an increased demand in the upcoming years for research activities in immunology and diabetes. Moreover, genetically engineered rats are recording a wider demand among scientists for studies pertaining to cardiovascular diseases like stroke and hypertension.

From a geographical perspective, U.S. and Canada are the key contributors to the growth of animal model market in North America. Experts claim that Canada industry is slated to register 11.9% CAGR through 2027, attributable to mounting cases of infectious diseases and presence of advanced healthcare infrastructure in the country.

Key players influencing the market trends are TransGenic Inc., The Jackson Laboratory, Taconic Biosciences, PharmaLegacy Laboratories, Janvier Labs, Harbour BioMed, GenOway S.A., Envigo, and Charles River Laboratories Intl. Inc.

Chat with us